Therapeutic Drug Monitoring of Vedolizumab in Inflammatory Bowel Disease Patients during Maintenance Treatment-TUMMY Study

• Hoofdauteurs: Merve Sivridaş (Auteur), Rob H. Creemers (Auteur), Dennis R. Wong (Auteur), Paul J. Boekema (Auteur), Tessa E. H. Römkens (Auteur), Lennard P. L. Gilissen (Auteur), Adriaan A. van Bodegraven (Auteur), Floris C. Loeff (Auteur), Theo Rispens (Auteur), Luc J. J. Derijks (Auteur)
• Formaat: Boek
• Gepubliceerd in: MDPI AG, 2023-03-01T00:00:00Z.
• Onderwerpen: article
• Online toegang: Connect to this object online.

There are limited data on therapeutic drug monitoring (TDM) in inflammatory bowel disease (IBD) patients treated with vedolizumab (VDZ). Although an exposure-response relation has been demonstrated in the post-induction phase, this relationship is more uncertain in the maintenance phase of treatment...